| Abbreviation | Product Name | Product number | Applications |
| HBR-6 | HBR Active blocker 6 | BAC006 | HAMAelimination |
| HBR-5 | HBR Active blocker 5 | BAC005 | HAMAelimination |
| HBR-4 | HBR Active blocker 4 | BAC004 | Rheumatoid factor elimination |
| HBR-2 | HBR Active blocker 2 | BAC002 | Rheumatoid factor elimination |
| SLO | Streptolysin O | T004 | |
| S1 | SARS-CoV-2 (2019- nCoV) Spike Protein (S1 Subunit) | T002 | |
| RBD | SARS-CoV-2 (2019- nCoV) Spike Protein (RBD, Mouse Fc Tag) | T003 | |
| N protein | Recombinant SARS- CoV-2 Nucleocapsid Protein | T005 | |
| CG-G6PDH | CG-G6PDH protein conjugate | T006 | |
| CG-BSA | CG-BSA protein conjugate | T001 | |
| CoV-2 N(MAB4) | SARS-CoV-2 N protein antibody （mab4) | HMA 10-4 | Immunochromatography |
| CoV-2 N(MAB3) | SARS-CoV-2 N protein antibody （mab3) | HMA 10-3 | Immunochromatography |
| CoV-2 N(MAB2) | SARS-CoV-2 N protein antibody （mab2) | HMA 10-2 | Immunochromatography |
| CoV-2 N(MAB1) | SARS-CoV-2 N protein antibody （mab1) | HMA 10-1 | Immunochromatography |
| SAA（MAB2） | Human SAA antibody （mab2） | HMA 06-2 | |
| SAA（MAB1） | Human SAA antibody （mab1） | HMA 06-1 | latex-enhanced immunoturbidimetry |
| PG II（MAB2） | Human PGII antibody （mab2） | HMA 11-2 | latex-enhanced immunoturbidimetry |
| PG II（MAB1） | Human PGII antibody （mab1） | HMA 11-1 | latex-enhanced immunoturbidimetry |
| lpa（MAB2） | Human Lpa antibody （mab2） | Lpa antibody （mab2） HMA 04-2 | latex-enhanced immunoturbidimetry |
| lpa（MAB1） | Human Lpa antibody （mab1） | HMA 04-1 | latex-enhanced immunoturbidimetry |
CN
